Psychedelic Stocks Index Declined 4% On Monday
December 22, 2020 at 04:48 AM EST
This article tracks the performance of 15 of the 31 bio-pharmaceutical companies involved in the research and development of psychedelic compounds to treat mental health issues such as OCD, PTSD, opioid & alcohol addiction, depression and anxiety.
